Eli Lilly and CompanyLLYNYSE
Loading
LLY Revenue Growth (YoY Quarterly)•+42.56%
Stock Alarm Pro
Growth Metrics
Latest: Q4 2025vs Q3 2025
Revenue GrowthGross Profit GrowthEBITDA GrowthOperating Income GrowthNet Income GrowthEPS GrowthEPS Diluted GrowthWeighted Average Shares GrowthWeighted Average Shares Diluted GrowthDividends per Share Growth
+42.56%
-11.3pp
+47.44%
-10.0pp
+45.92%
-204.7pp
+51.36%
-33.0pp
+50.48%
-424.9pp
+50.92%
-425.0pp
+51.43%
-428.9pp
+0.05%
+0.5pp
-0.57%
+0.1pp
+0.00%
+0.0pp
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +44.68% | +45.17% | +37.64% | +53.87% | +42.56% |
| Gross Profit Growth | +47.10% | +48.06% | +43.55% | +57.45% | +47.44% |
| EBITDA Growth | +89.42% | +33.58% | +82.35% | +250.64% | +45.92% |
| Operating Income Growth | +81.57% | +97.70% | +61.28% | +84.32% | +51.36% |
| Net Income Growth | +101.39% | +23.02% | +90.78% | +475.34% | +50.48% |
| EPS Growth | +102.06% | +23.29% | +91.49% | +475.93% | +50.92% |
| EPS Diluted Growth | +101.65% | +23.39% | +91.77% | +480.37% | +51.43% |
| Weighted Average Shares Growth | -0.20% | -0.31% | -0.33% | -0.46% | +0.05% |
| Weighted Average Shares Diluted Growth | -0.09% | -0.35% | -0.49% | -0.69% | -0.57% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +42.85% | +110.54% | +138.04% | +30.35% |
| Free Cash Flow Growth | +0.00% | -990.87% | +1923.66% | +0.00% | -6.70% |
| Receivables Growth | +17.11% | +39.84% | +31.55% | +61.45% | +51.82% |
| Inventory Growth | +31.46% | +52.59% | +69.93% | +63.28% | +81.10% |
| Asset Growth | +22.98% | +39.79% | +40.41% | +52.02% | +42.89% |
| Book Value per Share Growth | +32.02% | +23.43% | +35.19% | +67.85% | +86.87% |
| Debt Growth | +33.37% | +46.94% | +38.11% | +36.59% | +26.33% |
| R&D Expense Growth | +17.94% | +8.36% | +23.05% | +26.76% | +25.79% |
| SG&A Expenses Growth | +27.58% | +28.65% | +32.19% | +38.11% | +44.82% |
1 / 4